QIAGEN MANSFIELD INC has a total of 19 patent applications. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets biotechnology and measurement are LISTER PREVENTIVE MED, JINAN ADICON CLINICAL LABORATORIES INC and UNION STEMCELL & GENE ENG CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Singapore | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Divakar Kiran Madanahally | 16 |
#2 | Nolling Jork | 8 |
#3 | Kong Lilly I | 8 |
#4 | Lei Jason | 3 |
#5 | Kiran Madanahally Divakar | 2 |
#6 | Jork Nolling | 1 |
#7 | Kong Lilly L | 1 |
#8 | Lilly I Kong | 1 |
#9 | Voronov Sergey V | 1 |
Publication | Filing date | Title |
---|---|---|
US2016130660A1 | Compositions and methods for multimodal analysis of cmet nucleic acids | |
SG11201600755TA | Compositions and methods for multiplex analysis of nras and braf nucleic acids | |
CA2865163A1 | Multimodal pcr target detection |